Sort by
Refine Your Search
-
Employer
-
Field
-
the dynamics of therapy-resistance by combining advanced molecular biology method development to multi-omic single-cell analyses of both ex vivo models and clinical tumor specimens. Our novel, in-house
-
genetics, gene therapy, CRISPR-based gene editing, stem cell technologies, and translational disease modelling. We are particularly interested in developing treatments for retinal disorders prevalent in
-
microscopy-based imaging, flow cytometry, single-cell omics technologies, and functional immunological analyses. The research group is located in the MediCity Research Laboratory of the Faculty of Medicine
Enter an email to receive alerts for mobile-developer-"https:"-"UCL" positions